Is there any role for surgery in the multidisciplinary treatment of esophageal cancer?

Annals of Oncology

Volumn 21, Issue SUPPL. 7, 2010, Pages

  Stahl, M ^a  

^a KLINIKEN ESSEN MITTE   (Germany)

Author keywords

Chemoradiotherapy; Esophageal cancer; Multidisciplinary treatment

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL; VINBLASTINE;

CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONFERENCE PAPER; DRUG RESPONSE; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; ESOPHAGUS SURGERY; HUMAN; LOWER ESOPHAGUS SPHINCTER; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; GUIDELINES AS TOPIC; HUMANS;

EID: 78649346121     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdq294     Document Type: Conference Paper

References (20)

1. Pyre CG, Hagen JA, DeMeester SR et al. Predicting systemic disease in patients with esophageal cancer after esophagectomy: a multinational study on the significance of the number of involved lymph nodes. Ann Surg 2008; 248: 979-985.
2. Coia LR, Minsky BD, John MJ et al. The evaluation and treatment of patients receiving radiation therapy for carcinoma of the esophagus. Results of the 1992-1994 patterns of care study. Cancer 1999; 85: 2499-2505.
3. UICC. Sobin LH, Gospodarowicz MK, Wittekind C (eds): TNM Classification of Malignant Tumours, 7th edn. Oxford: Wiley-Blackwell 2009.
4. Wong R, Malthaner R. Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus. Cochrane Database Syst Rev 2003; issue 1: CD002092.
5. Stahl M, Stuschke M, Lehmann N et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 2005; 23: 2311-2317.
6. Bedenne L, Michel P, Bouche O et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol 2007; 25: 1160-1168.
7. Chang DT, Chapman C, Shen J et al. Treatment of esophageal cancer based on histology. Am J Clin Oncol 2009; 32: 405-410.
8. Herskovic A, Martz K, Al-Sarraf M et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992; 326: 1593-1598.
9. Walsh TN, Noonan N, Hollywood D et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Eng J Med 1996; 335: 462-467.
10. Urba SG, Orringer MB, Turrisi A et al. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 2001; 19: 305-313.
11. Burmeister BH, Smithers MB, Gebski V et al. Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. Lancet Oncol 2005; 6: 659-668.
12. Tepper J, Krasna MJ, Niedwiecki D et al. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol 2008; 26: 1086-1092.
13. Urschel JD, Vasan H. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery with surgery alone for resectable esophageal cancer. Am J Surg 2003; 185: 538-543.
14. Fiorica F, Di Bona D, Schepis A et al. Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis. Gut 2004; 53: 925-930.
15. Stuschke M, Sarbia M. Neoadjuvante radiochemotherapie und responseprädiktion. Onkologe 2004; 10: 1179-1190.
16. Jouve J, Michel P, Mariette C et al. Outcome of the nonrandomized patients in the FFCD 9102 trial: chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus. J Clin Oncol 2008; 26 (Suppl): 220s (Abstr 4555).
17. Bartels H, Stein HJ, Siewert JR. Preoperative risk and postoperative mortality of oesophagectomy for resectable oesophageal cancer. Br J Cancer 1998; 85: 840-844.
18. Bitzer M, Stahl M, Arjumand J et al. C-myc gene amplification in different stages of oesophageal squamous cell carcinoma: prognostic values in relation to treatment modality. Anticancer Res 2003; 23: 1489-1494.
19. Sivula A, Buskens CJ, van Rees BP et al. Prognostic role of cycloogygenase-2 in neoadjuvant-treated patients with squamous cell carcinoma of the esophagus. Int J Cancer 2005; 116: 903-908.
20. Kato H, Nakajima M, Sohda M et al. The clinical application of 18F-fluorodeoxyglucose positron emission tomography to predict survival in patients with operable esophageal cancer. Cancer 2009; 115: 3196-3203.